IPIRA Startups

IPIRA Startups

OnWafer Technologies, Inc.

Brief Description

OnWafer Technologies, Inc. manufactures lithography and plasma etch products to the semiconductor industry. The company's products include Baketemp, which allows temperature monitoring of resist track bake plates; Onview data analysis system, a process viewing system; Bakeinfo analysis engine, which tracks the thermal profile of various plates for viewing and identifying excursion events; Autocal, a software application; AutoCD, which pushes the servo point forward; and SmartFOUP that contains sealed on-board diagnostics systems. Its mobile metrology solutions feature...

OneD Battery Sciences

Brief Description

In 2013, the company acquired nanowire technologies and Palo Alto R&D activities from Nanosys.

Today, OneD Battery Sciences operates a SiNANODE® pilot production to support the development of advanced electrochemical cells and the initial production of its technology licensees.

OneD Baterry Sciences CTO Dr. Yimin Zhu leads a team that continues to improve the SiNANODE® technology and supports customers producing advanced energy storage solutions for various markets.

OneD Battery Science engages with leading material suppliers, battery makers, and...

OncoRx Pharmaceuticals, Inc.

Brief Description

OncoRx Pharmaceuticals is an early-stage pharmaceutical company discovering and developing targeted therapies that control the progression of invasive malignant cancer. OncoRx has identified and tested drugs that markedly alter the sustained directional mobility, the uncontrolled cell cycle, and t​​he unrestrained growth and proliferation of intrinsically and acquired therapy-resistant tumors. Unlike non-aggressive primary tumors, the growth, progression and invasiveness of therapy-resistant tumors are not effectively controlled with currently available cancer therapies...

Oncobionic

Brief Description

Oncobionic commercialized irreversible electroporation (IRE) technology, a minimally invasive treatment for tumors that revolutionized cancer therapy. The minimally invasive surgical system delivers 1,500 volts of electric current through needle-like probes, ablating the targeted area, making it possible to remove unresectable tumors near critical structures and major blood vessels without cuts or incisions. IRE exclusively targets the tumor’s cell membranes, leaving critical organs, vasculature, ducts and nerves completely unharmed.

The IRE...

OmniTact

Brief Description

OmniTact was founded to commercialize a robotic manipulation sensor designed by researchers at UC Berkeley. The sensor uses micro-cameras to detect multi-directional deformations of a gel-based skin. It is designed to be used as a fingertip for robotic manipulation with robotic hands, and uses multiple micro-cameras to detect multi-directional deformations. This provides a rich signal from which a variety of different contact state variables can be inferred using modern image processing and computer vision methods.

Inventors

Roberto Calandra, Frederik David Ebert,...

Omniox, Inc.

Brief Description

Omniox is an early stage biopharmaceutical company developing new medicines for hypoxic diseases. Hypoxia (oxygen deficiency) impacts cancer, cardiovascular diseases, trauma and many other conditions. The company has engineered an unusually stable oxygen carrier technology (H-NOX) to deliver oxygen into hypoxic tissues and improve the treatment of severe unmet medical needs. The technology overcomes the modes of failure of prior efforts in the field of oxygen therapeutics.

Inventors

Elizabeth Boon, Stephen Cary, Michael Marletta, Emily Weinert, Jonathan Winger...

Ogma Scientific

Brief Description

Ogma Scientific works with clients in the energy, mining and agriculture sectors and clients in the chemical industry to identify innovative treatment strategies for problems in industrial ecosystems. Our high-throughput screening services are uniquely tailored to identify successful treatments to stop undesirable microbial activity that impacts industrial processes. Examples include biosouring in the oil sector and acid mine drainage in the mining sector. Biosouring alone, caused by the inadvertent stimulation of microbial activity during oil or gas recovery, costs the...

O.N. Diagnostics, LLC

Brief Description

O.N. Diagnostics was founded by UC Berkeley Professor of Mechanical Engineering Tony M. Keaveny based on biomedical engineering research conducted at UC Berkeley and UC San Francisco. The company's mission is to improve patient outcomes by developing non-invasive and clinically effective diagnostic applications that quantitatively exploit the richness of information in CT scans. The company achieves scientific and technological excellence through rigorous research and validation, combined with the highest industry standards in execution and quality control....

Nurix

Brief Description

Nurix is pioneering rational drug design in the emerging field of protein regulation by targeting E2 conjugating enzymes and E3 ligases that control the Ubiquitin Proteasome System (UPS).

Regulation of protein stability by the UPS is modulated by the activity of these E2 and E3 enzymes, which control the tagging of proteins with ubiquitin for degradation by the proteasome. The human genome encodes approximately 1,000 different E3 ligases and 60 E2 enzymes. A number of these ligases recently have been shown to play key roles in human diseases, particularly in cancer...

Nodexus, Inc.

Brief Description

Nodexus is commercializing an integrated, “one-click” platform that is low-cost, compact, and provides a simplified workflow to deliver enriched single cells of interest from a wide variety of samples such as stem cells, transfected cell lines, cultured cell lines, dissociated tissue, and whole blood.

Inventors

Lydia Sohn, Daniel Yang, George Anwar, James Hack, Karthik Balakrishnan, Matthew Chambers, Matthew Chapman

Company Founders

Karthik Balakrishnan (UC Berkeley, M.S., Mechanical Engineering, 2011; Ph.D., Doctor of Philosophy, Mechanical Engineering,...